Neurostimulation Can Relieve Chronic Pain, Experts Conclude
the Neurology Advisor take:
Evidence shows that neurostimulation can be used to treat chronic pain, according to a new report from an international team of experts.
Neurostimulation stimulates pain-sensing nerves to convert painful sensations into non-painful ones. It provides a minimally invasive, reversible alternative to medication to alleviate chronic pain, a lasting condition that may affect up to 15% of the adult population.
Members of the International Neuromodulation Society’s Neuromodulation Appropriateness Consensus Committee evaluated literature reviews, expert opinions, clinical experience, and individual research reports to gauge the safety and effectiveness of neurostimulation as a treatment for chronic pain.
The experts specifically looked at neurostimulation as a treatment for conditions including failed back surgery syndrome, post herpetic neuralgia, phantom limb pain, and complex regional pain syndrome. More studies need to be conducted for other conditions, such as peripheral neuropathic pain, postamputation pain, and nerve pain from shingles.
Neurostimulation is not linked to medication-related side effects, and it provides a lasting effect. Although complications from the procedure are not uncommon, they are becoming less frequent with the advancement of technology and improvement of surgical skills.
The experts selected members of the international scientific community to further their research by analyzing scientific evidence that could lead to innovations in neurostimulation and using clinical experience to fill in any gaps in information.
In addition to treating chronic pain, neurostimulation has the potential to treat non-pain states such as obesity, Alzheimer’s disease, obsessive compulsive disorder, and addiction.
Neurostimulation therapy relieves chronic pain
Members of the International Neuromodulation Society's Neuromodulation Appropriateness Consensus Committee conclude that neurostimulation can be a life-changing therapy for patients with chronic pain, as well as subjects with other conditions including Alzheimer's disease, obsessive compulsive disorder, and addiction.
Next Article in Pain
Neurology Advisor Articles
- Rasagiline Plus Riluzole is Safe, May Improve Survival in ALS
- Treatment of New-Onset Epilepsy: AAN, AES Update Practice Guidelines
- Gender Differences in the Epidemiology of Migraine
- Changes in Glucose Regulation in Parkinson Disease
- Apomorphine Infusions Improves Off Time Associated With Parkinson Disease
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- Cannabis for Multiple Sclerosis: Prescriber's Perspective
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications
- Locally Asymptomatic Ischemic Stroke May Present as Migraine Aura
- Associations Identified Between Stroke Severity, Recovery of Visuospatial Neglect
- Action Tremor May Have Central Origin in Motor Neuron Disease
- Characteristics Affecting Health-Related Quality of Life in RRMS, Progressive MS
- Neurodevelopmental Anomalies, Birth Defects Linked to Zika ID'd